Ivan Hyep

Chief Financial Officer

Ivan Hyep (Chief Financial Officer) filed 10 Form 4 reports in the trailing twelve months (0 purchases, 10 sales), most often in Bicara Therapeutics Inc. (BCAX). The largest single filing was $783K of BCAX (27,170 sh across 2 lots, as filed), executed Jul 8.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 10 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$3.1M

shares × price, as filed

Last traded

Aug 10

Filed Aug 12

Median ADV $19.3M across their filed names

Open performance→

Volume by month

Buys $0 Sells $3.1M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 10 filings

Sector per market data · by filing · past 12 months

Most traded names

BCAX

Bicara Therapeutics Inc. BCAX · 0 buys · 10 sells 10 filings

Recent filings

BCAXSALE Bicara Therapeutics Inc. View filing → $350K
12,500 sh × $27.97
Exec Aug 10
Filed Aug 12 · 4:19 PM ET BCAXSALE Bicara Therapeutics Inc. View filing → $783K
27,170 sh across 2 lots
Exec Jul 8
Filed Jul 10 · 4:10 PM ET BCAXSALE Bicara Therapeutics Inc. View filing → $188K
9,200 sh × $20.42
Exec May 21
Filed May 26 · 5:30 PM ET BCAXSALE Bicara Therapeutics Inc. View filing → $212K
9,200 sh × $23.00
Exec Apr 21
Filed Apr 22 · 5:30 PM ET BCAXSALE Bicara Therapeutics Inc. View filing → $170K
9,200 sh × $18.52
Exec Mar 23
Filed Mar 24 · 5:30 PM ET BCAXSALE Bicara Therapeutics Inc. View filing → $247K
13,555 sh × $18.22
Exec Mar 3
Filed Mar 5 · 5:30 PM ET BCAXSALE Bicara Therapeutics Inc. View filing → $168K
9,200 sh × $18.31
Exec Dec 22 2025
Filed Dec 23 2025 · 5:30 PM ET BCAXSALE Bicara Therapeutics Inc. View filing → $330K
17,795 sh × $18.55
Exec Nov 24 2025
Filed Nov 25 2025 · 5:30 PM ET More filings →